请使用支持JavaScript的浏览器! Medchemexpress/Verteporfin(Synonyms: CL 318952)/HY-B0146/100mg_蚂蚁淘,【正品极速】生物医学科研用品轻松购|ebiomall 蚂蚁淘商城
商品信息
联系客服
Medchemexpress/Verteporfin(Synonyms: CL 318952)/HY-B0146/100mg
郑重提醒:
无质量问题不接受退换货,下单前请仔细核对信息。
下单后请及时联系客服核对商品价格,订单生效后再付款。
Medchemexpress/Verteporfin(Synonyms: CL 318952)/HY-B0146/100mg
美元价:
(友情提示:该价格仅为参考,欢迎联系客服询价!)
数    量:
免费咨询热线
4000-520-616
VerteporfinisabenzoporphyrinderivativemonoacidringA,andcaninhibittheactivityofYAP.
Description

VerteporfinisabenzoporphyrinderivativemonoacidringA,andcaninhibittheactivityofYAP.

InVitro

VerteporfinisspecificallyselectedbyPDX-cellscreening.Theconcentrationstocause50%growthinhibition(GI50)forPhLO,PhLH,andPhLKare228nM,395nM,and538nM,respectively,whereasGI50forALL-1,TCC-Y/sr,andNPhA1are3.93µM,2.11µM,and5.61µM,respectively.GSHsignificantlyreducesthesensitivityof2outof3PDXcellstoverteporfin.VerteporfinreducesthemitochondrialmembranepotentialinPDXcells[1].VerteporfinreducesthePTX-resistanceonHCT-8/TcellsbyinhibitingYAPexpressionandcombinationtherapywithverteporfinandpaclitaxel(PTX)showssynergismoninhibitionofYAPandcytotoxicitytoHCT-8/T[2].

InVivo

Verteporfin(10mg/kg,c.s.c.)anddasatinibsignificantlyreducestheleukemiacellratio,andcombinedtherapyfurtherreducedthenumberofleukemiacellsinthespleen[1].

ClinicalTrial
ViewMoreCollapse
References
  • [1].MorishitaT,etal.Thephotosensitizerverteporfinhaslight-independentanti-leukemicactivityforPh-positiveacutelymphoblasticleukemiaandsynergisticallyworkswithdasatinib.Oncotarget.2016Aug2.

    [2].PanW,etal.VerteporfincanReversethePaclitaxelResistanceInducedbyYAPOver-ExpressioninHCT-8/TCellswithoutPhotoactivationthroughInhibitingYAPExpression.CellPhysiolBiochem.2016;39(2):481-90.

PreparingStockSolutions
ConcentrationVolumeMass1mg5mg10mg
1mM1.3912mL6.9561mL13.9123mL
5mM0.2782mL1.3912mL2.7825mL
10mM0.1391mL0.6956mL1.3912mL
Pleaserefertothesolubilityinformationtoselecttheappropriatesolvent.
CellAssay
[1]

VerteporfinisdissolvedinDMSO.

PDXcellsco-culturedwithS17cellsaretreatedwith16combinationsofverteporfin(60nM,120nM,180nM,and240nM)anddasatinib(12nM,24nM,36nM,and48nM).TheviABIlitiesofcellstreatedwitheachcombinationaremeasuredafter48husingFACSAriaflowcytometer.Inordertoestimatedruginteractionbetweenverteporfinanddasatinib,anormalizedisobologramandfractionaffectedcombinationindex(CI)plotaremadeusingCompuSynsoftware.CIvaluesgreaterthan1.0indicatedantagoNISTiceffects,equalto1.0additiveeffects,andbelow1.0synergisticeffects.MCEhasnotindependentlyconfirmedtheaccuracyofthesemethods.Theyareforreferenceonly.

AnimalAdministration
[1]

PhLOcells(1.0×107/mouse)areinjectedintravenouslyinto6-week-oldmaleNOGmice,whicharethentreatedwithvehicle,verteporfin(140mg/kg/day),dasatinib(20mg/kg/day),andacombinationofthesedrugsfromdays22to28.Verteporfinisadministeredbycontinuoussubcutaneousinfusion(c.s.c.)usingAlzetosmoticpumps.Anintraperitonealinjection(i.p.)isperformedfordasatinib.Allmicearesacrificedonday28andthechimerismofleukemiacellsisinvestigatedbyflowcytometerusingananti-humanCD19antibodyandantimouseCD45antibody.BloodconcentrationsofverteporfinarecalculatedbyLCMS-2020.MCEhasnotindependentlyconfirmedtheaccuracyofthesemethods.Theyareforreferenceonly.

References
  • [1].MorishitaT,etal.Thephotosensitizerverteporfinhaslight-independentanti-leukemicactivityforPh-positiveacutelymphoblasticleukemiaandsynergisticallyworkswithdasatinib.Oncotarget.2016Aug2.

    [2].PanW,etal.VerteporfincanReversethePaclitaxelResistanceInducedbyYAPOver-ExpressioninHCT-8/TCellswithoutPhotoactivationthroughInhibitingYAPExpression.CellPhysiolBiochem.2016;39(2):481-90.

MolecularWeight

718.79

Formula

C₄₁H₄₂N₄O₈

CASNo.

129497-78-5

Storage
Powder-20°C3years
 4°C2years
Insolvent-80°C6months
 -20°C1month
Shipping

RoomtemperatureincontinentalUS;mayvaryelsewhere

Solvent&Solubility

DMSO:5.6mg/mL

*"<1 mg/ml"="" means="" slightly="" soluble="" or="" insoluble.="" "≥"="" means="" soluble,="" but="" saturation="">

Purity:99.26%